精准医学时代的组织取样:为临床试验或肿瘤基因组学进行的经皮活检与常规临床诊疗活检的比较
该单中心回顾性研究比较了60例为基因图谱分析行经皮活检的患者与60例连续常规活检对照患者,发现基因图谱组平均活检针数更多(3.45 vs 2.18,p=0.0001)、平均活检次数更多(1.44 vs 1.08,p=0.0002),但并发症发生率未见可检测的升高,仅6例并发症且均为肺活检所致气胸。
要点
- 为基因图谱或临床试验入组而行的活检,平均活检针数(3.45)高于常规活检(2.18)。
- 基因图谱组平均接受1.44次影像引导活检,多于对照组的1.08次。
- 120例中仅6例并发症,均为肺活检气胸,仅2例需治疗,针数增加与并发症风险无显著关系。
核心结论
- 为基因图谱或临床研究入组而活检的患者接受更多活检操作和更多活检针数,但在这项小样本、单中心研究中未检测到并发症发生率的增加。
研究设计与样本
- 单中心回顾性研究,60例为基因图谱分析行经皮活检的患者与60例连续常规活检对照患者进行比较,采用t检验和logistic回归分析。
诊断标准与关键数值
- 120例中仅6例并发症,对照组4例、研究组2例,均为肺活检患者的气胸,其中仅2例需要治疗。
局限性
- 原文结论自述该研究为小样本、单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of the study was to determine if patients undergoing percutaneous biopsy for genetic profiling are undergoing more biopsies (procedures, passes per procedure), or experiencing more procedure-related complications.
METHODS: 60 patients undergoing biopsy procedures for genetic profiling were retrospectively compared with 60 consecutive control patients undergoing routine biopsies. Procedural details and related complications were collected. Results were analyzed using t-tests and logistic regression.
RESULTS: Biopsied organs included mainly lung (n = 31), liver (n = 50), and lymph nodes (n = 18). The average number of core biopsy passes was 3.45 in the study group and 2.18 in the control group (0.73, 1.81; p = 0.0001). The average study patient underwent 1.44 biopsy procedures by radiology from 2016 to 2017, whereas the average control patient underwent 1.08 (0.1657, 0.5010, p = 0.0002). Results were similar when looking at the subset of patients undergoing liver biopsies. In our cohort of 120 patients total, only 6 complications were noted. There were 4 complications in the control patients and 2 complications in the study patients, all of which were pneumothoraces in patients undergoing lung biopsy; only 2 of these required treatment. The odds ratio for a complication occurring from an increase in one core biopsy is 1.07 (0.601, 1.573; p = 0.775), suggesting no significant relationship among the number of biopsies taken and the probability of complication in this cohort.
CONCLUSIONS: Patients being biopsied for genetic profiling or clinical study enrollment are undergoing more biopsy procedures and more biopsy passes per procedure, but are not experiencing a detectable increased rate of complications in this small cohort, single-center study.
引用
- Cherukuri AR, Lubner MG, Zea R, et al. Tissue sampling in the era of precision medicine: comparison of percutaneous biopsies performed for clinical trials or tumor genomics versus routine clinical care. Abdom Radiol (NY). 2019. PMID: 30032384. doi:10.1007/s00261-018-1702-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。